Skip to content
Screener

Adaptive Biotechnologies ADPT Total Assets

Total Assets at other companies

Biodesix, Inc. logo
Biodesix, Inc.BDSX
$95.33M+8.6%
Guardant Health logo
Guardant HealthGH
$1.92B+42.5%
Natera, Inc. logo
Natera, Inc.NTRA
$2.66B+51.2%
GeneDx Holdings logo
GeneDx HoldingsWGS
$506.3M+13.4%
Personalis, Inc. logo
Personalis, Inc.PSNL
$325.4M+19.1%
Myriad Genetics logo
Myriad GeneticsMYGN
$673.7M-33.0%

Other financials

Income statement

See full
Revenue$70.9M+35.1%
Gross profit$52.2M+47.1%
Operating income-$19.2M+35.1%
Net income-$20.0M+32.9%
EPS (diluted)-$0.13+35.0%

Balance sheet

See full
Cash & equivalents$77.6M+53.2%
Total debt$208.2M-5.6%
Total equity$216.3M+13.6%

Cash flow

See full
Operating cash flow-$9.5M+66.5%
CapEx$796.0K-36.8%
Free cash flow-$10.3M+65.3%

Valuation

See full
Market cap$3.75B+111%
Enterprise value$3.88B+98.7%
P/S12.7×+4.0×

Profitability

See full
Gross margin75.3%+12.7pp
Operating margin-15.8%-7.0pp
Net margin-16.8%-7.3pp
FCF margin-10.5%-4.6pp

Returns & leverage

See full
Return on equity-24.4%-9.2pp
Debt / equity1×-0.2×
Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:30 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206546
Line itemMarch 31, 2026December 31, 2025
Intangible assets, net1,3071,726
Goodwill118,972118,972
Other assets1,2371,207
Total assets$505,943$512,736
Liabilities and shareholders’ equity
Current liabilities
Accounts payable$9,615$6,467
Accrued liabilities7,4657,700

Item 1. Financial Statements (Unaudited)

FAQ

What is Adaptive Biotechnologies's total assets?
Adaptive Biotechnologies (ADPT) reported total assets of $505.94M in Q1 2026.
How has Adaptive Biotechnologies's total assets changed year-over-year?
Adaptive Biotechnologies's total assets decreased by 1.0% year-over-year, from $510.85M to $505.94M.
What is the long-term trend for Adaptive Biotechnologies's total assets?
Over 5 years (2020 to 2025), Adaptive Biotechnologies's total assets has grown at a -14.4% compound annual growth rate (CAGR), from $1.12B to $512.74M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.

Ask your AI about Adaptive Biotechnologies's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude